Verona Pharma plc - American Depositary Share (VRNA) Social Stream
VERONA PHARMA PLC (VRNA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering VRNA.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 5 | $25 | $17 | $20.6 | $18.86 | 9.23% |
| 2022-01-24 | 4 | $25 | $17 | $21.6 | $18.86 | 14.53% |
| 2022-05-23 | 5 | $25 | $17 | $21.6 | $18.86 | 14.53% |
| 2022-07-27 | 5 | $25 | $17 | $20.2 | $18.86 | 7.1% |
| 2022-08-09 | 5 | $30 | $20 | $24.2 | $18.86 | 28.31% |
| 2022-08-26 | 6 | $31 | $20 | $25.333 | $18.86 | 34.32% |
| 2022-08-29 | 6 | $31 | $20 | $26.166 | $18.86 | 38.74% |
| 2022-11-06 | 6 | $31 | $20 | $26.833 | $18.86 | 42.27% |
| 2022-12-18 | 5 | $31 | $20 | $26.8 | $18.86 | 42.1% |
| 2022-12-20 | 6 | $31 | $20 | $26.8 | $18.86 | 42.1% |
| 2023-02-07 | 6 | $33 | $26 | $30 | $18.86 | 59.07% |
| 2023-03-06 | 5 | $35 | $26 | $30.333 | $18.86 | 60.83% |
| 2023-03-13 | 6 | $35 | $26 | $30.333 | $18.86 | 60.83% |
| 2023-05-10 | 6 | $35 | $28 | $31.142 | $18.86 | 65.12% |
| 2023-06-02 | 6 | $38 | $28 | $31.857 | $18.86 | 68.91% |
| 2023-08-04 | 6 | $38 | $30 | $32.428 | $18.86 | 71.94% |
| 2023-09-11 | 7 | $38 | $30 | $32.714 | $18.86 | 73.46% |
| 2023-11-08 | 7 | $38 | $31 | $33.142 | $18.86 | 75.73% |
The Trend in the Analyst Price Target
VRNA's average price target has moved up $2 over the prior 28 weeks.
Over the past 42 weeks, VRNA's average upside potential has been 64.25%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-07 | 5 | 33 | 26 | 30.000 | 22.32 | 34.41% |
| 2023-03-23 | 6 | 35 | 28 | 31.142 | 19.85 | 56.89% |
| 2023-06-07 | 6 | 38 | 30 | 32.428 | 20.69 | 56.73% |
| 2023-08-04 | 6 | 38 | 30 | 32.428 | 19.93 | 62.71% |
| 2023-09-01 | 7 | 38 | 30 | 32.714 | 19.40 | 68.63% |
VRNA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 7 | 0 | 0 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 16 months, VRNA's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for VRNA as an investment opportunity.
- VERONA PHARMA PLC's number of analysts covering the stock is greater than 603.27% of all US stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, VERONA PHARMA PLC's variance in analysts' estimates is lower than -351.05% of them.
- VRNA has a higher average analyst price target than 1647.83% of stocks in the small market cap category.
- VRNA has a higher upside potential (average analyst target price relative to current price) than 772.99% of Pharmaceutical Products stocks.
Stocks similar to VERONA PHARMA PLC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are URGN, VBIV, and ATNF.
View All Top Stocks by Price Target
What is the outlook for VRNA? Use POWR Ratings for clearer insight into price direction.